Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage

Neurology

Volumn 54, Issue 4, 2000, Pages 872-878

  Hop, Jeannette W ^a   Rinkel, G J E ^a   Algra, A ^a   Berkelbach Van Der Sprenkel, J W ^a,b   Van Gijn, J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Julius Ctr Patient Oriented Res ^*  (Netherlands)

Author keywords

Aspirin; Clinical trial; Platelets; Subarachnoid hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; BRAIN ARTERY ANEURYSM RUPTURE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG SCREENING; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; SUPPOSITORY; TREATMENT OUTCOME;

EID: 0034701012     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.4.872     Document Type: Article

References (26)

1. Longstreth Jr WT, Nelson LM, Koepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology 1993;43:712-718.
2. Ljunggren B, Säveland H, Brandt L. Causes of unfavorable outcome after early aneurysm operation. Neurosurgery 1983; 13:629-633.
3. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg 1990;73:18-36.
4. van Gijn J. Subarachnoid haemorrhage. Lancet 1992;339:653-655.
5. White RP, Robertson JT. Role of plasmin, thrombin and anti-thrombin III as etiological factors in delayed cerebral vasospasm. Neurosurgery 1985;16:27-35.
6. Findlay JM, Macdonald RL, Weir BKA. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 1991;3:336-361.
7. Dorsch NW. Cerebral arterial spasm - a clinical review. Br J Neurosurg 1995;9:403-412.
8. Juvela S, Kaste M, Hillbom M. Platelet thromboxane release after subarachnoid hemorrhage and surgery. Stroke 1990;21: 566-571.
9. Ohkuma H, Suzuki S, Kimura M, Sobata E. Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1991;22:854-859.
10. Vinge E, Brandt L, Ljunggren B, Andersson KE. Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage. Stroke 1988;19:644-647.
11. Juvela S. Alcohol consumption as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. BMJ 1992;304:1663-1667.
12. Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 1995;82:945-952.
13. Hunt WE, Kassell NF, Pertuiset B, et al. Report of the World Federation of Neurological Surgeons Committee on a universal subarachnoid haemorrhage grading scale. J Neurosurg 1988;68:985-986.
14. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1998;330:1287-1294.
15. van Gijn J. Cerebral ischemia. Treatment and prevention. In: Barnett HJM, Hachinski VC, eds. Neurologic clinics. Philadelphia: WB Saunders, 1992:193-207.
16. Toghi H, Konno S, Tamura K, Kimura B, Kawano K. Effect of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke 1992;23: 1400-1403.
17. de Haan RJ, Limburg M, Bossuyt P, vander Meulen JHP, Aaronson NK. The clinical meaning of Rankin "handicap" grades after stroke. Stroke 1995;26:2027-2030.
18. Bergner M, Bobbit RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;29:787-805.
19. McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
20. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
21. Jacobs HM, Luttik A, Touw-Otten FWMM, de Melker RA. The "Sickness Impact Profile." Results of a validation study of the Dutch version. Ned Tijdschr Geneeskd 1990;134:1950-1954. English abstract.
22. van der Zee K, Sanderman R, Heyink J. De psychometrische kwaliteiten van de MOS-36 Short Form Health Survey (SF-36) in een Nederlandse populatie. Tijdschr Soc Geneesk 1993; 71:183-191.
23. Brass LM. Trial design issues: endpoints and sample size. Cerebrovasc Dis 1995;5:3-11.
24. Hop JW, Rinkel GJE, Algra A, van Gijn J. Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke 1998;29:798-804.
25. Proust F, Hannequin D, Langlois O, Freger P, Creissard P. Causes of morbidity and mortality after ruptured aneurysm surgery in a series of 230 patients. Stroke 1995;26:1553-1557.
26. Kallis P, Tooze JA, Talbot S, Cowans D, Bevan DH, Treasure T. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss - a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 1994;8:404-409.